SCHEMBL13638642

SCHEMBL13638642

CNc1ccc2c(c1)N=C(c1ccc(NC(=O)NS(=O)(=O)c3ccc(C)s3)cc1C)C2=O

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 1/20 0.36
CA12 O43570 6/20 0.35
CA9 Q16790 6/20 0.35
CA1 P00915 3/20 0.35
CA2 P00918 2/20 0.35
FBP1 P09467 3/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
NAMPT P43490 1/20 0.33
KIT P10721 1/20 0.33
NLRP3 Q96P20 2/20 0.32
BRD4 O60885 1/20 0.32
CREBBP Q92793 1/20 0.32
MAPT P10636 1/20 0.32
IDH1 O75874 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13182852 0.91 P2RY12 (0.44) P2RY12CA12CA9CA1CA2
SCHEMBL12177379 0.91 MEN1 (0.41) P2RY12CA12CA9CA1CA2
SCHEMBL14113781 0.91 P2RY12 (0.36) P2RY12CA12CA9CA1CA2
SCHEMBL12177328 0.90 NAMPT (0.38) P2RY12CA12CA9CA1CA2
SCHEMBL13182861 0.86 CA12 (0.36) P2RY12CA12CA9CA1CA2
SCHEMBL9922221 0.84 P2RY12 (0.44) P2RY12FBP1MEN1KMT2AMAPT
SCHEMBL9923262 0.82 P2RY12 (0.48) P2RY12FBP1MEN1KMT2AMAPT
SCHEMBL9922370 0.82 P2RY12 (0.47) P2RY12FBP1MEN1KMT2AKIT
SCHEMBL13638712 0.81 CA12 (0.35) P2RY12CA12CA9CA1CA2
SCHEMBL13182849 0.78 NAMPT (0.41) CA12CA9CA1CA2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed